About Abgent
Abgent is a Healthcare company based in San Diego (United States) founded in 2001, and was acquired by WuXi AppTec in October 2011. Primary antibodies are developed for research and drug discovery. Its focus areas include Biopharma Outsourcing, CRO, Drug Discovery and Medicinal Chemistry. Its competitors include GenScript and Epitomics; 2 of its 2 listed competitors have raised funding.
Company details
Abgent was founded in 2001 in San Diego, United States, as a manufacturer focused on antibodies for biological research and drug discovery. A catalog of approximately 20,000 antibody products is maintained. Custom services, including antibody development, peptide synthesis, and protein expression, are provided to support research needs. The company was acquired by WuXi Apptec in October 2011, integrating its operations into broader scientific services.
- Headquarters San Diego, United States
- Stage Acquired
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Website abgent.com
- Social LinkedIn X
- Acquired by WuXi AppTec (Oct 2011)
- Investors
- Acquired byWuXi AppTec
(Oct 2011)
Investors in Abgent
Abgent has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include WuXi AppTec.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Provider of CRO and CDMO services | 2000 | wuxiapptec.com | Shanghai, China |
Investor details for Abgent
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Abgent
2 dated milestones of Abgent across 10 years, from founding to its latest funding, stage changes and deals.
- Founded Abgent is founded.
- Exit Acquired by WuXi AppTec.
Competitors of Abgent
Abgent has 2 listed competitors in our database, 2 of them funded. They include GenScript and Epitomics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| genscript.com | 2002 | Piscataway, United States | $15M | 5,260 | Reagents and instruments are provided for life sciences research. | |
| epitomics.com | 2001 | Burlingame, United States | $16.21M | Monoclonal antibody technology and products are developed by Epitomics. |
Detailed competitors of Abgent
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Abgent
Websites that share an audience with Abgent (abgent.com).
Websites whose visitors overlap most with Abgent. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| abnova.com | 100% | 30.7K | #957,320 | View details | |
acris-antibodies.com | acris-antibodies.com | 100% | #11,446,421 | β | |
| epitomics.com | 100% | View details | |||
| ptglab.com | 99% | #137,673 | View details | ||
| imgenex.com | 98% | View details | |||
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 28 similar websites and full traffic analytics for Abgent
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 28 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Abgent (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Abgent
Abgent was founded in 2001.
Abgent is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Abgent was founded in 2001 in San Diego, United States, as a manufacturer focused on antibodies for biological research and drug discovery. A catalog of approximately 20,000 antibody products is maintained. Custom services, including antibody development, peptide synthesis, and protein expression, are provided to support research needs. The company was acquired by WuXi Apptec in October 2011, integrating its operations into broader scientific services.
Abgent has 1 investor. Key investors include WuXi AppTec.
Yes. Abgent was acquired by WuXi AppTec in October 2011.
